Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension (Q43732342)

26 November 2017

title

Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension (English)

1 reference

26 November 2017

R H Steinhorn

1

1 reference

26 November 2017

G Albert

2

1 reference

26 November 2017

D D Swartz

3

1 reference

26 November 2017

J A Russell

4

1 reference

26 November 2017

C R Levine

5

1 reference

26 November 2017

J M Davis

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

164

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

834-839

1 reference

Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.5.2010104

10.1164/AJRCCM.164.5.2010104

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference